Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Avelas Biosciences
company
About
Avelas Biosciences develops real-time luminous maps for oncologic surgeons to refer while in surgery.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $20M
- Industries
- Biotechnology,Life Science,Real Time
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
At Avelas Biosciences, their mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$20M
Avelas Biosciences has raised a total of
$20M
in funding over 2 rounds. Their latest funding was raised on
Aug 18, 2016 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 18, 2016 | Series C | $20M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Avelas Biosciences is funded by 1 investors.
Inbio Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Inbio Ventures
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
